Company Info
| Phone: | (949) 238-8090 |
| Year Established: | 2004 |
| Ticker: | ELDN |
| Exchange: | NASDAQ |
Contacts
| Primary: | David-Alexandre C. Gros, MD CEO |
| Other: | David Hovland, PhD Chief Regulatory Officer Paul Little CFO Bryan Smith General Counsel Steven Perrin, PhD President & CSO Eliezer Katz, M.D., FACS CMO Carmen Mak, PhD VP, Biometrics |
Company Description
Eledon Pharmaceuticals, formerly Novus, is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS.
